-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Akebia Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2012 to 2023.
- Akebia Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$20M, a 38.3% decline year-over-year.
- Akebia Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$46M, a 21.5% increase year-over-year.
- Akebia Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$51.9M, a 44.9% increase from 2022.
- Akebia Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$94.2M, a 66.6% increase from 2021.
- Akebia Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$282M, a 26.7% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)